An Open-label, Fixed-sequence Study in Healthy Study Participants to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 12 Jul 2018
At a glance
- Drugs Padsevonil (Primary) ; Erythromycin
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors UCB Biopharma
- 02 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 11 Apr 2018 Status changed from not yet recruiting to recruiting.
- 03 Apr 2018 New trial record